Controlled drug legislation, medicines regulation and funding
How a medicine reaches an Australian patient, from TGA registration and the Poisons Standard schedules to PBAC cost-effectiveness and PBS restrictions, plus state Schedule 8 rules, real-time prescription monitoring, unapproved-medicine access and the 2026 co-payments.
Tier 2Topic overview
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
Four separate gates sit between a drug and an Australian patient:
Loading the rest of the note…
Finished reading?
Sources
- Standard for the Uniform Scheduling of Medicines and Poisons (the Poisons Standard)AU/NZTherapeutic Goods Administration
- Therapeutic Goods Act 1989AU/NZAustralian Government (Federal Register of Legislation)
- Fees, patient contributions and safety net thresholds (as at 1 July 2026)AU/NZPharmaceutical Benefits Scheme, 2026
- Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (version 5)AU/NZAustralian Government Department of Health
- National Medicines Policy 2022AU/NZAustralian Government Department of Health and Aged Care, 2022
- Special Access Scheme and Authorised Prescriber SchemeAU/NZTherapeutic Goods Administration
- Real time prescription monitoringAU/NZAustralian Government Department of Health and Aged Care
- Pharmac: the Pharmaceutical Management Agency (New Zealand)AU/NZPharmac Te Pātaka Whaioranga
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback